Sarcoma Alliance for Research Through Collaboration (SARC) Multicenter Trial: A Phase II Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas.

Trial Profile

Sarcoma Alliance for Research Through Collaboration (SARC) Multicenter Trial: A Phase II Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Mar 2013

At a glance

  • Drugs Perifosine (Primary)
  • Indications Chondrosarcoma; Sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jun 2011 Planned end date changed from 1 Jul 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 08 Jun 2011 Planned end date changed from 1 Jul 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 13 Feb 2009 Planned end date changed from 1 Dec 2008 to 1 Jul 2009, based on information from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top